3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
9
Head & Neck
6
Dermatologic
6
CNS
3
Myeloid
2
Lymphoid
2
Breast
2
Other hematologic neoplasm
1
Genitourinary
1
Gastrointestinal
1
Conditions
Leukemia, Myeloid, Acute
881
Precursor Cell Lymphoblastic Leukemia-Lymphoma
509
Hematologic Neoplasms
464
Leukemia, Lymphocytic, Chronic, B-Cell
392
Leukemia
335
Myelodysplastic Syndromes
329
Lymphoma
207
Lymphoma, Non-Hodgkin
191
Multiple Myeloma
146
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
142
Recurrence
138
Neoplasms
134
Leukemia, Myelomonocytic, Chronic
111
Lymphoma, Mantle-Cell
92
Lymphoma, Follicular
92
Burkitt Lymphoma
92
Lymphoma, Large B-Cell, Diffuse
91
Myeloproliferative Disorders
84
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
83
Leukemia, Biphenotypic, Acute
81
Lymphoma, B-Cell, Marginal Zone
75
Hodgkin Disease
72
Lymphoma, B-Cell
64
Waldenstrom Macroglobulinemia
54
Primary Myelofibrosis
53
Leukemia, B-Cell
52
Anemia, Refractory, with Excess of Blasts
46
Leukemia, Myeloid, Chronic-Phase
41
Hematologic Diseases
37
Lymphoma, T-Cell
33
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Soft Tissue Neoplasms
×
Other hematologic neoplasm
×
1 year
×
Clear all
NCT04996875
2026-05-05
APEX
Cogent Biosciences, Inc.
Phase 2
Recruiting
140 enrolled